UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Choosing an index fund for retirement involves comparing Sp500 vs total market exposure, costs, and long-term growth potential.
28,502 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Bitcoin steadies around the mid-50s as XRP, Solana, and PEPE push higher on evolving policy signals and renewed inves...
New wage data in early 2026 shows the payoff from switching jobs is fading. Movers earned roughly 4% in January, whil...
Top multifamily owners don’t wait for year-end reports. They review a concise set of metrics every quarter to steer l...
XRP’s fundamentals look solid after regulatory clarity, but the price action remains muted near $1.40 as institutiona...
Move, operator of Realtor.com, delivered a 10% year‑over‑year revenue gain in News Corp’s Q3 results. The broader com...
As 2026 begins, Tesla faces pressure on deliveries while BYD battles domestic slumps but advances fast charging and o...
Lineage and Rexford Industrial Realty offer starkly different paths in industrial real estate. This guide breaks down...
Bitcoin slipped from a brief rally as geopolitical headlines weighed on risk sentiment. Traders are watching on-chain...
Large LINK holders moved millions of tokens to Binance just days before a landmark banking initiative was unveiled, s...
Investors watch Nvidia for AI-driven gains, especially around key events. This guide uses history, data, and real-lif...
Cerebras signals an upcoming IPO as it presses to outpace Nvidia and rival AI-chip startups in the fast-moving genera...